The therapeutic effects of PJ34. [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)- N,N-dimethylacetamide, HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation
Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó, D. Craig Hooper
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The therapeutic effects of PJ34. [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)- N,N-dimethylacetamide, HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation'. Together they form a unique fingerprint.